ARCHIVES

BMI May Be Prognostic Tool For Types Of Breast Cancer

This article is from The Cancer Letter archive.

Vol. 31 No. 3 | March 28, 2008

Download PDF Visit The Full Archive

Related Articles

ODAC Recommends Femara Campath For FDA Approval.

January 5, 2001

NCI Begins Large National Clinical Trial To Validate Biomarker For Lung Cancer

October 31, 2008

Clinical Study Group Proposed To Examine Peer Review System

October 15, 1993

Insufficient Data To Prove Digital Mammograms Better, Michigan Consortium Finds

August 29, 2003

July issue of Business & Regulatory report (8 additional pages) included.

July 30, 2004

NCI Reportedly Gets $691 Million From House, Senate Conferees

October 4, 1974